Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser
Research output: Contribution to journal › Journal article › Research › peer-review
Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.
|Journal||Ugeskrift for Laeger|
|Number of pages||5|
|Publication status||Published - 14 Aug 2017|
- English Abstract, Journal Article